We are live on
!
Find out more
AA
AlphaCentric Advisors Portfolio holdings
AUM
$100M
This Fund
S&P 500
This Quarter
Est. Return
+3.46%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$368M
AUM Growth
+$71.7M
(+24%)
Cap. Flow
+$61.6M
Cap. Flow
% of AUM
16.74%
Top 10 Holdings %
Top 10 Hldgs %
80.73%
Holding
256
New
50
Increased
99
Reduced
30
Closed
47
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MBS ETF
MBB
|
+$24.9M |
| 2 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$23M |
| 3 |
Rithm Capital
RITM
|
+$2.6M |
| 4 |
Travere Therapeutics
TVTX
|
+$1.21M |
| 5 |
Ouster
OUST
|
+$907K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RAVN
Raven Industries Inc
RAVN
|
+$1.53M |
| 2 |
LAZR
Luminar Technologies
LAZR
|
+$1.22M |
| 3 |
uniQure
QURE
|
+$1.09M |
| 4 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$1.09M |
| 5 |
AgEagle Aerial Systems
UAVS
|
+$783K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Real Estate | 18.83% |
| 2 | Healthcare | 12.69% |
| 3 | Technology | 1.7% |
| 4 | Industrials | 0.97% |
| 5 | Financials | 0.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
iShares MBS ETF
MBB
$39.3B
| $131M | 35.57% |
1,210,000
+230,000
| +23% | +$24.9M |
|
|
2
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.5B
| $91M | 24.71% |
1,705,000
+430,000
| +34% | +$23M |
|
3
Invitation Homes
INVH
$17.9B
| $31.9M | 8.65% |
854,144
| – | – |
|
4
American Homes 4 Rent
AMH
$12.3B
| $31.3M | 8.51% |
806,924
| – | – |
|
5
Stereotaxis
STXS
$154M
| $3.13M | 0.85% |
325,000
| – | – |
|
|
6
Rithm Capital
RITM
$5.2B
| $2.6M | 0.71% |
+245,158
| New | +$2.6M |
|
7
Intuitive Surgical
ISRG
$122B
| $1.84M | 0.5% |
6,000
| – | – |
|
8
Synopsys
SNPS
$73.6B
| $1.52M | 0.41% |
5,500
+500
| +10% | +$127K |
|
9
Omnicell
OMCL
$2.09B
| $1.51M | 0.41% |
10,000
| – | – |
|
10
AeroVironment
AVAV
$7.2B
| $1.5M | 0.41% |
15,000
+2,500
| +20% | +$275K |
|
|
LKFT
11
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.97B
| $1.48M | 0.4% |
21,500
+4,500
| +26% | +$343K |
|
12
Vertex Pharmaceuticals
VRTX
$123B
| $1.46M | 0.4% |
7,250
+3,250
| +81% | +$680K |
|
13
Azenta
AZTA
$1.21B
| $1.43M | 0.39% |
15,000
-5,000
| -25% | -$485K |
|
14
Ametek
AME
$54.3B
| $1.33M | 0.36% |
10,000
| – | – |
|
15
iShares 1-3 Year Treasury Bond ETF
SHY
$25.7B
| $1.3M | 0.35% |
15,060
+4,911
| +48% | +$424K |
|
16
Allient
ALNT
$1.49B
| $1.29M | 0.35% |
37,500
| – | – |
|
17
Regeneron Pharmaceuticals
REGN
$70.9B
| $1.15M | 0.31% |
2,050
-750
| -27% | -$380K |
|
|
NNDM
18
Nano Dimension
NNDM
$326M
| $1.11M | 0.3% |
135,000
+35,000
| +35% | +$259K |
|
19
Sarepta Therapeutics
SRPT
$1.82B
| $1.09M | 0.3% |
14,000
+4,500
| +47% | +$341K |
|
20
Accuray
ARAY
$30.8M
| $1.06M | 0.29% |
235,000
+10,000
| +4% | +$46.8K |
|
|
21
Ouster
OUST
$2.49B
| $1.06M | 0.29% |
+8,500
| New | +$907K |
|
|
BLUE
22
DELISTED
bluebird bio
BLUE
| $1.05M | 0.29% |
2,548
-347
| -12% | -$137K |
|
|
VIRX
23
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $1.05M | 0.28% |
92,402
| – | – |
|
|
CYBE
24
DELISTED
Cyberoptics Corp
CYBE
| $1.02M | 0.28% |
25,000
| – | – |
|
25
Novanta
NOVT
$5.3B
| $1.01M | 0.27% |
7,500
| – | – |
|
Similar funds
WCM
FCM
BIA
AGAM
E
HCM
AC
OIS
AlphaCentric Advisors's Q2 2021 Portfolio in Review
As of Q2 2021, AlphaCentric Advisors held 256 positions worth $368M, up 24% from $297M the previous quarter. Its ten largest holdings account for 81% of the portfolio.
AlphaCentric Advisors deployed $61.6M of net new capital in Q2 2021, opening 50 new positions and adding to 99 existing holdings. Its largest new stake was Rithm Capital: 245,158 shares worth $2.6M.
By sector, the portfolio is most concentrated in Real Estate at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Azenta, an estimated $485K trimmed.
- AlphaCentric Advisors's largest Q2 2021 buy was Rithm Capital: 245,158 shares worth $2.6M.
- AlphaCentric Advisors added most to iShares MBS ETF in Q2 2021, an estimated $24.9M increase.
- AlphaCentric Advisors's biggest Q2 2021 reduction was Azenta, cutting an estimated $485K.
- AlphaCentric Advisors fully exited Raven Industries Inc in Q2 2021, selling an estimated $1.53M.
- AlphaCentric Advisors's ten largest holdings make up 81% of its $368M portfolio in Q2 2021.
- AlphaCentric Advisors opened 50 new positions and closed 47 in Q2 2021.
- AlphaCentric Advisors's portfolio value rose 24% quarter-over-quarter to $368M.
Based on AlphaCentric Advisors's 13F filing for Q2 2021, filed 9 Mar 2022.